Skip to content

A COMPARATIVE CLINICAL STUDY ON THE COMBINED EFFECT OF ASHMARIHAR KWATH AND ASHMARIHAR RAS IN KIDNEY STONE

A COMPARATIVE CLINICAL STUDY ON THE COMBINED EFFECT OF ASHMARIHAR KWATH AND ASHMARIHAR RAS IN ASHMARI (UROLITHIASIS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025943
Enrollment
30
Registered
2020-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N22- Calculus of urinary tract in diseases classified elsewhere Health Condition 2: N22- Calculus of urinary tract in diseases classified elsewhere

Interventions

Intervention1: ASHMARIHAR KWATH AND ASHMARIHAR RAS: ASHMARI HAR KWATH and ASHMARIHAR RAS have six content with mutral, ashmari bhedana properties. Control Intervention1: not applicable: not applicable

Sponsors

patanjali ayurvedic college haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients having sign and symptoms of mutrashmari is included viz. pain in the region of umbilicus, perineum and dome of the bladder, experience od severe pain on movement of the urine is included. patients of both sexes above the age of 18 years irrespective of religion, socioeconomic status and occupation patients having renal/ ureteric/ bladder calculi with or without mild hydronephrosis patients complaining burning or dribbling micturition or both

Exclusion criteria

Exclusion criteria: individuals with complications related to kidneys/ ureter / bladder.e.g. acute renal failure, chronic renal failure, polycystic kidney diseases, impaired renal function, etc. patients of ashmari having systemic diseases like, IHD (ischemic heart disease), RHD (rheumatic heart disease), AIDS (acquired deficiency syndrome) other chronic diseases like TB (tuberculosis) etc pregnant women and lactating mothers & children below age of 18 years patients having moderate or severe hydronephrosis patients will be dropped if they developed any complications during the course

Design outcomes

Primary

MeasureTime frame
reduction of calculi size reduction of pain normalcy in micturitionTimepoint: 12 weeks

Secondary

MeasureTime frame
to reduce hydronephrosisTimepoint: 3 months

Countries

India

Contacts

Public Contacthema goswami

rishikul campus uttarakhand ayurved university haridwar

akg1409@gmail.com9412856414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026